After binding to the IL-17 receptor (IL-17R), IL-17A is functionally involved in the pathogenesis of several autoimmune diseases, such as psoriasis, rheumatoid arthritis (RA), lupus, inflammatory bowel disease (IBD), and multiple sclerosis (MS) [5]. Here, IL17A is linked to inflammatory bowel disease.